Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers

X Deng, J Wang, S Yu, S Tan, T Yu, Q Xu, N Chen… - …, 2024 - Wiley Online Library
Atherosclerosis, a chronic disease associated with metabolism, poses a significant risk to
human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency …

[HTML][HTML] Recent advances in three-dimensional printing in cardiovascular devices: Bench and bedside applications

Y Shen, J Cui, X Yu, J Song, P Cai, W Guo… - Smart Materials in …, 2023 - Elsevier
Abstract Three-dimensional (3D) printing is emerging as an innovative technology, which is
widely used in cardiovascular disease at bench and bedside. During the last decade, with …

3D printed personalized, heparinized and biodegradable coronary artery stents for rabbit abdominal aorta implantation

Y Shen, C Tang, B Sun, Y Zhang, X Sun… - Chemical Engineering …, 2022 - Elsevier
Biodegradable stents have become the focus of attention in the field of interventional
medicine. Compared to non-biodegradable stents, these stents are designed to degrade …

Alterations in gut microbiota and host transcriptome of patients with coronary artery disease

L Chen, X Mou, J Li, M Li, C Ye, X Gao, X Liu, Y Ma… - BMC microbiology, 2023 - Springer
Background Coronary artery disease (CAD) is a widespread heart condition caused by
atherosclerosis and influences millions of people worldwide. Early detection of CAD is …

[HTML][HTML] Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale …

RW de Winter, SJ Walsh, CG Hanratty, JC Spratt… - American heart …, 2023 - Elsevier
Background Patients with prior coronary artery bypass grafting (CABG) frequently require
repeat percutaneous revascularization due to advanced age, progressive coronary artery …

Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia–reperfusion injury: unfolding new epigenetic …

K Liu, H Wang, Y Wang, X Zhang, R Wang, Z Zhang… - Clinical …, 2024 - Springer
Background The management of myocardial ischemia–reperfusion injury (MIRI) presents
continuous therapeutic challenges. NAD-dependent deacetylase Sirtuin 6 (Sirt6) plays …

Multi-Omics Profiling of Human Endothelial Cells from the Coronary Artery and Internal Thoracic Artery Reveals Molecular but Not Functional Heterogeneity

A Frolov, A Lobov, M Kabilov, B Zainullina… - International Journal of …, 2023 - mdpi.com
Major adverse cardiovascular events occurring upon coronary artery bypass graft surgery
are typically accompanied by endothelial dysfunction. Total arterial revascularisation, which …

Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta‐analysis of 14 …

S Nagraj, A Tzoumas, F Kakargias… - Catheterization and …, 2022 - Wiley Online Library
Objectives To compare the outcomes of hybrid coronary revascularization (HCR) with
traditional coronary artery bypass grafting (CABG) in multivessel coronary artery disease …

Intensive Lipid‐Lowering Therapy as per the Latest Dyslipidemia Management Guideline in Predicting Favorable Long‐Term Clinical Outcomes in Patients …

L Tang, H Chen, XQ Hu, ZF Fang, XB Liao… - Journal of the …, 2023 - Am Heart Assoc
Background There are limited data on low‐density lipoprotein cholesterol (LDL‐C) goal
achievement per the 2019 European Society of Cardiology/European Atherosclerosis …

Acute coronary syndromes among patients with prior coronary artery bypass surgery

DS Palm, A Drame, DJ Moliterno, D Aguilar - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review Acute coronary syndromes (ACS) often occur in individuals with
prior coronary artery bypass graft surgery (CABG). Our goal was to describe the prevalence …